Nu Skin Enterprises, Inc. (NUS) stock
NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/3068% below fair value
$4.03+0.02 (+0.50%)
Close on Nov 13, 2026Market cap $196.17MP/E –Yield –
Earnings
Nu Skin Enterprises's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Feb 11, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$311.00M
-14.6% on a year earlier
excluding certain charges, Q3 FY2026
$0.10
$0.34 a year earlier
Latest guidance
Issued
Nov 5, 2026 · 6 items
Quarterly results
Revenue and earnings per share from each of Nu Skin Enterprises's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 11, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 5, 2026after the close | $311.00M | -14.6% | -$0.02 | $0.10 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 10, 2026during market hours | $320.10M | -17.1% | -$5.14 | $0.20 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 7, 2026during market hours | – | – | – | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 12, 2026during market hours | $370.30M | – | $0.29 | $0.29 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 6, 2025during market hours | $364.21M | -15.3% | $0.34 | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 7, 2025during market hours | $386.10M | -12.1% | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 8, 2025during market hours | $364.50M | -12.7% | $2.14 | $0.23 | Release |
| Q4 FY2024ended Dec 31, 2024 | Jan 13, 2025before the open | – | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 7, 2024during market hours | $430.10M | -13.8% | $0.17 | $0.17 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 8, 2024during market hours | $439.10M | -12.2% | -$2.38 | $0.21 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 8, 2024during market hours | $417.30M | -13.3% | -$0.01 | $0.09 | Release |
| Q4 FY2023ended Dec 31, 2023 | Jan 8, 2024before the open | – | – | – | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 1, 2023during market hours | $498.80M | -7.3% | -$0.74 | $0.56 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 1, 2023during market hours | $500.30M | – | $0.54 | $0.54 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 3, 2023during market hours | $481.50M | -20.4% | $0.23 | $0.37 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 15, 2023during market hours | $522.30M | -22.4% | $1.15 | $0.89 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 2, 2022during market hours | $537.80M | – | -$0.51 | $0.47 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 8, 2022during market hours | – | – | – | – | Release |
| Q1 FY2022ended Mar 31, 2022 | May 4, 2022during market hours | $604.90M | – | $0.76 | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 16, 2022before the open | $673.40M | – | -$0.18 | $1.11 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 4, 2021during market hours | – | – | – | – | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 4, 2021during market hours | – | – | – | – | Release |
| Q1 FY2021ended Mar 31, 2021 | May 5, 2021during market hours | – | – | – | – | Release |
| Q4 FY2020ended Dec 31, 2020 | Feb 11, 2021before the open | – | – | – | – | Release |
| Q3 FY2020ended Sep 30, 2020 | Oct 2, 2020during market hours | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Nu Skin Enterprises's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| revenue | Q4 FY2026 | $310.00M – $340.00M | – | New | Nov 5, 2026 |
| earnings per shareGAAP | Q4 FY2026 | $0.05 – $0.15 | – | New | Nov 5, 2026 |
| adjusted basisnon-GAAP | Q4 FY2026 | $0.11 – $0.21 | – | New | Nov 5, 2026 |
| annual revenue guidance | FY2026 | $1.35B – $1.50B | – | New | Feb 12, 2026 |
| revenue | FY2026 | $1.26B – $1.29B | – | New | Nov 5, 2026 |
| RevenueGAAP | FY2026 | $1.28B – $1.35B | – | New | Aug 10, 2026 |
| Revenue | FY2026 | -9% – +1% | – | New | Feb 12, 2026 |
| earnings per shareGAAP | FY2026 | -$5.08 – -$4.98 | – | New | Nov 5, 2026 |
| EPSGAAP | FY2026 | -$4.90 – -$4.73 | – | New | Aug 10, 2026 |
| EPS | FY2026 | $0.80 – $1.20 | – | New | Feb 12, 2026 |
| adjusted basisnon-GAAP | FY2026 | $0.70 – $0.90 | – | New | Aug 10, 2026 |
| adjusted EPSnon-GAAP | FY2026 | $0.55 – $0.65 | – | New | Nov 5, 2026 |
| forecasted tax rate | FY2026 | 35% | – | New | Feb 12, 2026 |
Guidance vs results
The last range Nu Skin Enterprises gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | adjusted basis | $0.10 – $0.20 | $0.10 | Within range |
| Q3 FY2026 | EPS (GAAP) | $0.00 – $0.09 | -$0.02 | Below range |
| Q3 FY2026 | Revenue | $310.00M – $340.00M | $311.00M | Within range |
| FY2025 | Revenue | $1.48B – $1.51B | $1.49BΣ4Q | Within range |
| Q4 FY2025 | EPS (GAAP) | $0.25 – $0.35 | $0.29 | Within range |
| Q4 FY2025 | Revenue | $365.00M – $400.00M | $370.30M | Within range |
| Q3 FY2025 | EPS (GAAP) | $0.25 – $0.35 | $0.34 | Within range |
| Q3 FY2025 | Revenue | $360.00M – $390.00M | $364.21M | Within range |
| Q2 FY2025 | Revenue | $355.00M – $390.00M | $386.10M | Within range |
| Q2 FY2025 | Revenue growth | -19% – -11% | -12.07% | Within range |
| Q3 FY2024 | Adjusted EPS | $0.15 – $0.25 | $0.17 | Within range |
| Q3 FY2024 | EPS (GAAP) | $0.08 – $0.18 | $0.17 | Within range |
| Q3 FY2024 | Revenue | $430.00M – $465.00M | $430.10M | Within range |
| Q2 FY2024 | EPS (GAAP) | $0.01 – $0.10 | -$2.38 | Below range |
| Q2 FY2024 | EPS non-GAAP | $0.10 – $0.20 | $0.21 | Above range |
| Q2 FY2024 | Revenue | $420.00M – $455.00M | $439.10M | Within range |
| Q3 FY2023 | EPS (GAAP) | $0.54 – $0.69 | -$0.74 | Below range |
| Q3 FY2023 | Revenue | $500.00M – $540.00M | $498.80M | Below range |
| Q2 FY2023 | EPS (GAAP) | $0.45 – $0.55 | $0.54 | Within range |
| Q2 FY2023 | Revenue | $485.00M – $525.00M | $500.30M | Within range |
| Q4 FY2022 | EPS (GAAP) | $0.30 – $0.50 | $1.15 | Above range |
| Q4 FY2022 | Revenue | $500.00M – $550.00M | $522.30M | Within range |
| Q1 FY2022 | EPS (GAAP) | $0.65 – $0.75 | $0.76 | Above range |
| Q1 FY2022 | Revenue | $560.00M – $590.00M | $604.90M | Above range |
Guidance history
Every forecast Nu Skin Enterprises put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 5, 2026 | adjusted basis | Q4 FY2026 | $0.11 – $0.21 | New |
| Nov 5, 2026 | adjusted EPS | FY2026 | $0.55 – $0.65 | New |
| Nov 5, 2026 | earnings per share | Q4 FY2026 | $0.05 – $0.15 | New |
| Nov 5, 2026 | earnings per share | FY2026 | -$5.08 – -$4.98 | New |
| Nov 5, 2026 | revenue | Q4 FY2026 | $310.00M – $340.00M | New |
| Nov 5, 2026 | revenue | FY2026 | $1.26B – $1.29B | New |
| Aug 10, 2026 | adjusted basis | FY2026 | $0.70 – $0.90 | New |
| Aug 10, 2026 | adjusted basis | Q3 FY2026 | $0.10 – $0.20 | New |
| Aug 10, 2026 | EPS | FY2026 | -$4.90 – -$4.73 | New |
| Aug 10, 2026 | EPS | Q3 FY2026 | $0.00 – $0.09 | New |
| Aug 10, 2026 | Revenue | FY2026 | $1.28B – $1.35B | New |
| Aug 10, 2026 | Revenue | Q3 FY2026 | $310.00M – $340.00M | New |
| Feb 12, 2026 | EPS | FY2026 | $0.80 – $1.20 | New |
| Feb 12, 2026 | earnings per share | Q1 FY2026 | $0.10 – $0.20 | New |
| Feb 12, 2026 | forecasted tax rate | FY2026 | 35% | New |
| Feb 12, 2026 | Revenue | FY2026 | -9% – +1% | New |
| Feb 12, 2026 | annual revenue guidance | FY2026 | $1.35B – $1.50B | New |
| Feb 12, 2026 | Revenue | Q1 FY2026 | -12% – -7% | New |
| Feb 12, 2026 | Revenue | Q1 FY2026 | $320.00M – $340.00M | New |
| Nov 6, 2025 | adjusted EPS | FY2025 | $1.25 – $1.35 | New |
| Nov 6, 2025 | 2025 EPS | FY2025 | $3.15 – $3.25 | New |
| Nov 6, 2025 | Q4 2025 EPS | Q4 FY2025 | $0.25 – $0.35 | New |
| Nov 6, 2025 | 2025 Revenue | FY2025 | $1.48B – $1.51B | New |
| Nov 6, 2025 | Q4 2025 Revenue | Q4 FY2025 | $365.00M – $400.00M | New |
| Aug 7, 2025 | adjusted EPS | FY2025 | $1.15 – $1.35 | Raised |
| Aug 7, 2025 | Q3 2025 EPS | Q3 FY2025 | $0.25 – $0.35 | New |
| Aug 7, 2025 | 2025 EPS | FY2025 | $3.05 – $3.25 | Raised |
| Aug 7, 2025 | Q3 2025 Revenue | Q3 FY2025 | $360.00M – $390.00M | New |
| Aug 7, 2025 | 2025 Revenue | FY2025 | $1.48B – $1.55B | Lowered |
| May 8, 2025 | EPS excluding Mavely gain and other charges | FY2025 | $0.90 – $1.30 | New |
| May 8, 2025 | EPS | Q2 FY2025 | $0.20 – $0.30 | New |
| May 8, 2025 | EPS | FY2025 | $2.80 – $3.20 | New |
| May 8, 2025 | FX impact | Q2 FY2025 | -3% – -2% | New |
| May 8, 2025 | FX impact | FY2025 | -3% | New |
| May 8, 2025 | Revenue Growth Rate | Q2 FY2025 | -19% – -11% | New |
| May 8, 2025 | Revenue Growth Rate, excluding Mavely | Q2 FY2025 | -17% – -9% | New |
| May 8, 2025 | Revenue | Q2 FY2025 | $355.00M – $390.00M | New |
| May 8, 2025 | Revenue Growth Rate | FY2025 | -15% – -6% | New |
| May 8, 2025 | Revenue Growth Rate, excluding Mavely | FY2025 | -11% – -3% | New |
| May 8, 2025 | Revenue | FY2025 | $1.48B – $1.62B | New |
| Nov 7, 2024 | EPS non-GAAP | Q4 FY2024 | $0.19 – $0.29 | New |
| Nov 7, 2024 | EPS non-GAAP | FY2024 | $0.65 – $0.75 | Lowered |
| Nov 7, 2024 | EPS | Q4 FY2024 | -$0.09 – $0.01 | New |
| Nov 7, 2024 | EPS | FY2024 | -$2.32 – -$2.22 | Lowered |
| Nov 7, 2024 | Revenue | Q4 FY2024 | $410.00M – $445.00M | New |
| Nov 7, 2024 | Revenue | FY2024 | $1.70B – $1.73B | New |
| Aug 8, 2024 | Adjusted EPS | Q3 FY2024 | $0.15 – $0.25 | New |
| Aug 8, 2024 | Adjusted EPS | FY2024 | $0.75 – $0.95 | Lowered |
| Aug 8, 2024 | EPS | Q3 FY2024 | $0.08 – $0.18 | New |
| Aug 8, 2024 | EPS | FY2024 | -$2.01 – -$1.81 | Lowered |
| Aug 8, 2024 | Revenue | Q3 FY2024 | $430.00M – $465.00M | New |
| Aug 8, 2024 | Revenue | FY2024 | $1.73B – $1.81B | Lowered |
| May 8, 2024 | EPS non-GAAP | Q2 FY2024 | $0.10 – $0.20 | New |
| May 8, 2024 | EPS non-GAAP | FY2024 | $0.95 – $1.35 | New |
| May 8, 2024 | EPS | Q2 FY2024 | $0.01 – $0.10 | New |
| May 8, 2024 | EPS | FY2024 | $0.77 – $1.16 | New |
| May 8, 2024 | Revenue | Q2 FY2024 | $420.00M – $455.00M | New |
| May 8, 2024 | Revenue | FY2024 | $1.73B – $1.87B | New |
| Nov 1, 2023 | adjusted EPS | FY2023 | $1.62 – $1.77 | Lowered |
| Nov 1, 2023 | reported EPS | FY2023 | -$0.10 – $0.05 | Lowered |
| Aug 1, 2023 | EPS excluding first quarter restructuring charges | FY2023 | $2.30 – $2.60 | Lowered |
| Aug 1, 2023 | reported earnings per share | Q3 FY2023 | $0.54 – $0.69 | New |
| Aug 1, 2023 | reported EPS | FY2023 | $2.15 – $2.45 | Lowered |
| Aug 1, 2023 | revenue | Q3 FY2023 | $500.00M – $540.00M | New |
| Aug 1, 2023 | annual revenue | FY2023 | $2.00B – $2.08B | Lowered |
| May 3, 2023 | non-GAAP EPS | FY2023 | $2.41 – $2.81 | New |
| May 3, 2023 | reported earnings per share | Q2 FY2023 | $0.45 – $0.55 | New |
| May 3, 2023 | reported EPS | FY2023 | $2.27 – $2.67 | New |
| May 3, 2023 | revenue | Q2 FY2023 | $485.00M – $525.00M | New |
| May 3, 2023 | annual revenue | FY2023 | $2.03B – $2.18B | Reaffirmed |
| Feb 15, 2023 | annual revenue guidance | FY2023 | $2.03B – $2.18B | New |
| Nov 2, 2022 | earnings per share... when excluding an anticipated fourth-quarter restructuring and impairment charge | Q4 FY2022 | $0.40 – $0.60 | New |
| Nov 2, 2022 | EPS... excluding charges associated with the second-half restructuring and impairment charges and our Q4 2021 exit from Grow Tech | FY2022 | $2.40 – $2.60 | Lowered |
| Nov 2, 2022 | reported earnings per share | Q4 FY2022 | $0.30 – $0.50 | New |
| Nov 2, 2022 | reported EPS | FY2022 | $1.25 – $1.45 | Lowered |
| Nov 2, 2022 | revenue | Q4 FY2022 | $500.00M – $550.00M | New |
| Nov 2, 2022 | revenue guidance | FY2022 | $2.20B – $2.25B | Lowered |
| Jul 8, 2022 | revenue | Q2 FY2022 | $557.00M – $562.00M | Lowered |
| May 4, 2022 | EPS | FY2022 | $3.60 – $3.90 | Lowered |
| May 4, 2022 | EPS | FY2022 | $3.60 – $3.90 | Lowered |
| May 4, 2022 | EPS | Q2 FY2022 | $0.75 – $0.85 | New |
| May 4, 2022 | Revenue | Q2 FY2022 | $590.00M – $620.00M | New |
| May 4, 2022 | Revenue | FY2022 | $2.51B – $2.62B | Lowered |
| Feb 16, 2022 | EPS | FY2022 | $4.05 – $4.45 | New |
| Feb 16, 2022 | EPS | Q1 FY2022 | $0.65 – $0.75 | New |
| Feb 16, 2022 | EPS | FY2022 | $4.05 – $4.45 | New |
| Feb 16, 2022 | Revenue | FY2022 | $2.66B – $2.77B | New |
| Feb 16, 2022 | Revenue | Q1 FY2022 | $560.00M – $590.00M | New |
| Oct 4, 2021 | revenue | Q3 FY2021 | $637.00M – $642.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Nu Skin Enterprises filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Update
- Results
- Results
- Results
- Results
See a number that looks wrong?